Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT – Get Free Report) passed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $0.00 and traded as high as $0.88. Xtant Medical shares last traded at $0.84, with a volume of 74,084 shares changing hands.
Xtant Medical Stock Performance
The company has a quick ratio of 1.22, a current ratio of 2.82 and a debt-to-equity ratio of 0.34.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently bought and sold shares of XTNT. Vanguard Group Inc. acquired a new position in Xtant Medical during the 3rd quarter valued at about $805,000. AMH Equity Ltd acquired a new position in Xtant Medical during the 3rd quarter valued at about $653,000. Sterling Investment Advisors Ltd. acquired a new position in Xtant Medical during the 3rd quarter valued at about $38,000. AWM Investment Company Inc. acquired a new position in Xtant Medical during the 3rd quarter valued at about $516,000. Finally, Goldman Sachs Group Inc. lifted its stake in shares of Xtant Medical by 156.7% in the 4th quarter. Goldman Sachs Group Inc. now owns 33,176 shares of the medical device company’s stock worth $37,000 after acquiring an additional 20,253 shares during the period. 69.33% of the stock is owned by institutional investors and hedge funds.
About Xtant Medical
Xtant Medical Holdings, Inc develops, manufactures, and markets regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. Its biomaterial products include OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSponge SC that fills bony defects in the subchondral region of joints; OsteoSelect DBM Putty for osteoinductive bone growth; OsteoSelect PLUS DBM Putty for use as a bone void filler and bone graft substitute in the pelvis, extremities, and posterolateral spine; OsteoFactor, which contains various proteins and peptides that support bone formation and remodeling; OsteoWrap; and OsteoVive Plus, a growth factor enriched cellular bone matrix.
Further Reading
- Five stocks we like better than Xtant Medical
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- MarketBeat Week in Review – 4/15 – 4/19
- How to Calculate Options Profits
- Comprehensive Analysis of PayPal Stock
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Intuitive Surgical Stock Can Trend Much Higher This Year
Receive News & Ratings for Xtant Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xtant Medical and related companies with MarketBeat.com's FREE daily email newsletter.
